The role of HIF prolyl hydroxylases in tumour growth

nork Jokilehto, Terhi, Jaakkola, Panu M
Argitaratua 2010

Prolyl Hydroxylase PHD3 Enhances the Hypoxic Survival and G1 to S Transition of Carcinoma Cells

nork Högel, Heidi, Rantanen, Krista, Jokilehto, Terhi, Grenman, Reidar, Jaakkola, Panu M.
Argitaratua 2011

Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy

nork Ålgars, Annika, Avoranta, Tuulia, Österlund, Pia, Lintunen, Minnamaija, Sundström, Jari, Jokilehto, Terhi, Ristimäki, Ari, Ristamäki, Raija, Carpén, Olli
Argitaratua 2014

Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases

nork Marxsen, Jan H., Stengel, Petra, Doege, Kathrin, Heikkinen, Pekka, Jokilehto, Terhi, Wagner, Thomas, Jelkmann, Wolfgang, Jaakkola, Panu, Metzen, Eric
Argitaratua 2004

Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer

nork Birkman, Eva‐Maria, Elzagheid, Adam, Jokilehto, Terhi, Avoranta, Tuulia, Korkeila, Eija, Kulmala, Jarmo, Syrjänen, Kari, Westermarck, Jukka, Sundström, Jari
Argitaratua izan da Cancer Med (2018)